Galderma Group AG
GALD
Classement en actions
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Prix de l'action
$224.81
Capitalisation boursière
$52.42B
Changement (1 jour)
6.31%
Changement (1 an)
31.28%
Pays
CH
Échange Galderma Group AG (GALD)
Catégorie
Healthcare
Ratio P/S pour Galderma Group AG (GALD)
Ratio P/S au October 2026 TTM : 8.92
Selon les derniers rapports financiers et le cours de l'action de Galderma Group AG, le ratio cours/ventes actuel (TTM) est 8.92. À la fin de 2024, le ratio P/S était de 5.38.
Historique du ratio P/S pour Galderma Group AG de 2021 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 8.92 | -3.45% |
| 2025 | 9.24 | 71.63% |
| 2024 | 5.38 | 56.84% |
| 2023 | 3.43 | -2.09% |
| 2022 | 3.51 | -13.02% |
| 2021 | 4.03 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 2.82 | -68.43% |
DE
|
|
| 3.02 | -66.17% |
DE
|
|
| 2.19 | -75.49% |
JP
|
|
| 7.04 | -21.08% |
IN
|
|
| 9.37 | 5.01% |
CN
|
